Back
Scout24 SE Vs. Aligos Therapeutics Industry Stock Comparison
Buy
69
SCOTF
Scout24 SE
Last Price:
$80.00
Seasonality Move:
-3.71%
Sell
46
ALGS
Aligos Therapeutics
Last Price:
$9.12
Seasonality Move:
-25.15%
Buy
69
Scout24 SE (SCOTF)
is a Buy
Is Scout24 SE a Buy, Sell or Hold?
-
The current Scout24 SE [SCOTF] share price is $80.00. The Score for SCOTF is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
SCOTF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $9.13. The Score for ALGS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCOTF Stock Price Chart
What is Scout24 SE's stock price today?
-
The Scout24 SE share price today is $80.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCOTF is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $9.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SCOTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.38 | Buy |
Relative Strength Index (14 RSI): | 75.82 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80 - 80) | Sell |
Bollinger Bands (100): | (80 - 80) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 59.78 | Buy |
Chaikin Money Flow: | 36736 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.49 - 8.95) | Buy |
Bollinger Bands (100): | (5.08 - 9.88) | Buy |
SCOTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80 | Sell |
20-day SMA: | 80 | Sell |
50-day SMA: | 80 | Sell |
200-day SMA: | 80 | Sell |
8-day EMA: | 17.78 | Buy |
20-day EMA: | 7.62 | Buy |
50-day EMA: | 3.14 | Buy |
200-day EMA: | 0.8 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9 | Buy |
20-day SMA: | 8.38 | Buy |
50-day SMA: | 7.33 | Buy |
200-day SMA: | 15.21 | Sell |
8-day EMA: | 8.94 | Buy |
20-day EMA: | 8.5 | Buy |
50-day EMA: | 8.05 | Buy |
200-day EMA: | 12.52 | Sell |
Scout24 SE Earnings Growth & SCOTF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Scout24 SE Technical Analysis
Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |